Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Clinical case giant malignant phyllodes tumor of the breast.

Created on 24 Aug 2026

Authors

Alan Hari Silva Amaya, Julio Caleb Arrieta Navarro, Álvaro M Ñaña-Córdova, Elkin J Peláez-Cruz, Sorely Pacovilca Chura

Published in

Journal of surgical case reports. Volume 2026. Issue 8. Pages rjag735. Epub Aug 23, 2026.

Abstract

Malignant phyllodes tumor is a rare and aggressive breast neoplasm with the potential for rapid and recurrent growth. We present the case of a 56-year-old woman from San Martín, Peru, with a left breast mass exhibiting exponential growth, ulceration, necrosis, and asymmetry. Physical examination revealed a multinodular, purplish-red, indurated, and slightly painful mass. Ultrasound showed a 12-cm hypoechoic, heterogeneous mass with areas of necrosis, increased vascularity, and contact with the muscle layer (Breast Imaging Reporting and Data System category 4). Core biopsy revealed a fibroepithelial neoplasm with high mitotic activity (10/10 HPF). The patient underwent left total mastectomy with subsequent margin extension and partial-thickness skin grafting, achieving complete resection and satisfactory recovery. This case highlights the challenges in the diagnosis and surgical management of this pathology in resource-limited settings where timely surgery plays a crucial role in treatment and prevents recurrence.

PMID:
42634637
Bibliographic data and abstract were imported from PubMed on 24 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement